Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Boston, MA 02115, USA.
Harvard Stem Cell Institute, Boston, MA 02115, USA; Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.
Cell Rep. 2021 Jan 5;34(1):108574. doi: 10.1016/j.celrep.2020.108574.
The zinc finger transcription factor SALL4 is highly expressed in embryonic stem cells, downregulated in most adult tissues, but reactivated in many aggressive cancers. This unique expression pattern makes SALL4 an attractive therapeutic target. However, whether SALL4 binds DNA directly to regulate gene expression is unclear, and many of its targets in cancer cells remain elusive. Here, through an unbiased screen of protein binding microarray (PBM) and cleavage under targets and release using nuclease (CUT&RUN) experiments, we identify and validate the DNA binding domain of SALL4 and its consensus binding sequence. Combined with RNA sequencing (RNA-seq) analyses after SALL4 knockdown, we discover hundreds of new SALL4 target genes that it directly regulates in aggressive liver cancer cells, including genes encoding a family of histone 3 lysine 9-specific demethylases (KDMs). Taken together, these results elucidate the mechanism of SALL4 DNA binding and reveal pathways and molecules to target in SALL4-dependent tumors.
锌指转录因子 SALL4 在胚胎干细胞中高度表达,在大多数成人组织中下调,但在许多侵袭性癌症中重新激活。这种独特的表达模式使 SALL4 成为一个有吸引力的治疗靶点。然而,SALL4 是否直接与 DNA 结合以调节基因表达尚不清楚,其在癌细胞中的许多靶标仍然难以捉摸。在这里,我们通过无偏置的蛋白质结合微阵列 (PBM) 筛选和靶向切割与释放使用核酸酶 (CUT&RUN) 实验,鉴定和验证了 SALL4 的 DNA 结合域及其保守结合序列。结合 SALL4 敲低后的 RNA 测序 (RNA-seq) 分析,我们发现了数百个新的 SALL4 直接在侵袭性肝癌细胞中调控的靶基因,包括编码组蛋白 3 赖氨酸 9 特异性去甲基酶 (KDMs) 的家族基因。总之,这些结果阐明了 SALL4 DNA 结合的机制,并揭示了 SALL4 依赖性肿瘤的靶向途径和分子。